The in vitro activity of cefbuperazone was compared with that of cefoxitin, moxalactam, and piperacillin against 305 strains of anaerobic bacteria. Piperacillin was the most active overall, inhibiting 97% of all anaerobes tested at 128 ,ug/ml. Cefbuperazone had poor activity against the Bacteroides fragilis group and Clostridium difficile (43 and 0% susceptible, respectively) but good activity (90.5%) against all other anaerobic bacterial species tested.
The ever increasing introduction of 1-lactam antibiotics into the antimicrobial market, along with expanded awareness of the importance of anaerobic bacteria in infectious diseases, has underlined the need for information on the efficacy of these agents against anaerobic bacteria (1) . It is important to note that methodological differences between laboratories may affect the results; thus, it is difficult to draw conclusions from a number of studies unless the same techniques are used throughout.
In this report, the activity against anaerobic bacteria of cefbuperazone, a new semisynthetic parenterally administered cephamycin antibiotic, was compared with that of cefoxitin, moxalactam, and piperacillin, drugs commonly used in anaerobic infections.
All bacteria were randomly selected recent clinical isolates from the Veterans Administration Wadsworth Medical Center, Los Angeles. Bacteria were identified by using established procedures (2, 3 
